November 10, 2003
Gilead Sciences to Present at Credit Suisse First Boston 2003 Healthcare Conference
John Martin, PhD, Gilead's President and Chief Executive Officer, will provide the keynote luncheon presentation on the history of Gilead Sciences on Wednesday, November 12, 2003 at 2:30 p.m. Eastern Time. Following this presentation, John Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of the company and an update on key business milestones at 4:00 p.m. Eastern Time.
To access the live webcast or the seven-day archive via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to view the webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide. The company has seven marketed products and focuses its research and clinical programs on anti-infectives. Headquartered in Foster City, Calif., Gilead has operations in the United States, Europe and Australia.
For more information on Gilead Sciences, please visit
www.gilead.com or call the Gilead Public Affairs Department at
Gilead Sciences Susan Hubbard, 650-522-5715 (Investor Relations)